Method Development and Optimization
Method Development and Optimization
This domain tests how a method is built and adjusted deliberately. Expect questions on column and mobile phase screening, pH and solvent choice, gradient design, robustness, forced degradation, and the adjustments permitted under USP <621>.
Building a method
- Screen stationary phases of different chemistry (C18, C8, phenyl-hexyl, mixed-mode, HILIC for very polar analytes) before tuning anything else.
- Choose pH from the analyte pKa: at least two units away for ionizable compounds, using a buffer whose working range covers that pH. Buffer choice also sets ionic strength and the UV cutoff.
- Pick the organic modifier (ACN usually gives lower viscosity and lower UV cutoff than methanol) and set the gradient slope so the critical pair elutes in the shallowest practical segment.
- Apply quality by design: vary pH, temperature, and %B deliberately, map the design space, and demonstrate robustness rather than assume it.
- Prove specificity by forced degradation and confirm system suitability (resolution, tailing, plate count, RSD) before each run.
Worked example
Transfer a 1.0 mL/min, 20 min gradient from 4.6 × 150 mm, 5 µm to 2.1 × 100 mm, 1.8 µm. Flow scales with diameter squared: 1.0 × (2.1²/4.6²) = 0.21 mL/min. Column volume ratio = (2.1² × 100)/(4.6² × 150) = 0.139. Holding gradient volume in column volumes constant, t = 20 × 0.139 × (1.0/0.21) = 13.2 min. Scale injection volume by the same area ratio (~0.21×) and verify dwell volume.
Traps
Shortening gradient time to speed a method up without rescaling gradient volume; exceeding USP <621> flow, length, or particle-size allowances without revalidation; treating a pH change as minor when it alters ionization; transferring a method without accounting for dwell.